<b>Background</b>: This study aimed to assess the impact of PSMA-PET/CT fusion imaging on target volume delineation in prostate cancer RT and to evaluate its effects on dosimetric parameters and PSA response, including intraprostatic boost. The gene discussed is FOLH1; the disease is prostate carcinoma.